nodes	percent_of_prediction	percent_of_DWPC	metapath
Ondansetron—HTR3A—enteric nervous system—Crohn's disease	0.119	0.429	CbGeAlD
Ondansetron—HTR3A—myenteric nerve plexus—Crohn's disease	0.09	0.325	CbGeAlD
Ondansetron—Wound—Prednisone—Crohn's disease	0.0216	0.0499	CcSEcCtD
Ondansetron—SLC47A2—digestive system—Crohn's disease	0.0191	0.0691	CbGeAlD
Ondansetron—Ear disorder—Mesalazine—Crohn's disease	0.011	0.0253	CcSEcCtD
Ondansetron—Hepatocellular injury—Mercaptopurine—Crohn's disease	0.0109	0.0252	CcSEcCtD
Ondansetron—Anorectal discomfort—Mesalazine—Crohn's disease	0.0108	0.025	CcSEcCtD
Ondansetron—Local reaction—Mesalazine—Crohn's disease	0.0107	0.0247	CcSEcCtD
Ondansetron—Foetor hepaticus—Mesalazine—Crohn's disease	0.0104	0.0241	CcSEcCtD
Ondansetron—Liver disorder—Mesalazine—Crohn's disease	0.00867	0.0201	CcSEcCtD
Ondansetron—SLC47A1—mammalian vulva—Crohn's disease	0.00763	0.0276	CbGeAlD
Ondansetron—Neoplasm malignant—Azathioprine—Crohn's disease	0.0076	0.0176	CcSEcCtD
Ondansetron—Feeling hot—Mesalazine—Crohn's disease	0.00753	0.0174	CcSEcCtD
Ondansetron—HTR3A—digestive system—Crohn's disease	0.00681	0.0246	CbGeAlD
Ondansetron—SLC47A1—digestive system—Crohn's disease	0.00669	0.0242	CbGeAlD
Ondansetron—Hepatocellular injury—Azathioprine—Crohn's disease	0.00649	0.015	CcSEcCtD
Ondansetron—Musculoskeletal pain—Mesalazine—Crohn's disease	0.00598	0.0138	CcSEcCtD
Ondansetron—Hepatocellular injury—Mesalazine—Crohn's disease	0.00591	0.0137	CcSEcCtD
Ondansetron—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00576	0.0133	CcSEcCtD
Ondansetron—Hepatic failure—Azathioprine—Crohn's disease	0.00524	0.0121	CcSEcCtD
Ondansetron—Immune system disorder—Mercaptopurine—Crohn's disease	0.00494	0.0114	CcSEcCtD
Ondansetron—Hepatic failure—Mesalazine—Crohn's disease	0.00477	0.011	CcSEcCtD
Ondansetron—Atrial fibrillation—Mesalazine—Crohn's disease	0.00453	0.0105	CcSEcCtD
Ondansetron—Toxic epidermal necrolysis—Azathioprine—Crohn's disease	0.00424	0.00981	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.00403	0.00931	CcSEcCtD
Ondansetron—Liver function test abnormal—Mesalazine—Crohn's disease	0.00396	0.00916	CcSEcCtD
Ondansetron—Aspartate aminotransferase increased—Mesalazine—Crohn's disease	0.00386	0.00894	CcSEcCtD
Ondansetron—SLC47A1—lymph node—Crohn's disease	0.00382	0.0138	CbGeAlD
Ondansetron—Skin disorder—Mercaptopurine—Crohn's disease	0.00377	0.00873	CcSEcCtD
Ondansetron—Asthma—Mesalazine—Crohn's disease	0.00371	0.00858	CcSEcCtD
Ondansetron—Bronchospasm—Mesalazine—Crohn's disease	0.00365	0.00844	CcSEcCtD
Ondansetron—Angina pectoris—Mesalazine—Crohn's disease	0.00361	0.00836	CcSEcCtD
Ondansetron—Stevens-Johnson syndrome—Azathioprine—Crohn's disease	0.0036	0.00833	CcSEcCtD
Ondansetron—CYP1A2—digestive system—Crohn's disease	0.00352	0.0127	CbGeAlD
Ondansetron—Dysuria—Mesalazine—Crohn's disease	0.00347	0.00802	CcSEcCtD
Ondansetron—Hepatobiliary disease—Azathioprine—Crohn's disease	0.00343	0.00794	CcSEcCtD
Ondansetron—CYP3A5—digestive system—Crohn's disease	0.00339	0.0123	CbGeAlD
Ondansetron—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.00335	0.00776	CcSEcCtD
Ondansetron—CYP2C9—digestive system—Crohn's disease	0.00334	0.0121	CbGeAlD
Ondansetron—Stevens-Johnson syndrome—Mesalazine—Crohn's disease	0.00328	0.00758	CcSEcCtD
Ondansetron—Haemoglobin—Azathioprine—Crohn's disease	0.00328	0.00758	CcSEcCtD
Ondansetron—Haemorrhage—Azathioprine—Crohn's disease	0.00326	0.00754	CcSEcCtD
Ondansetron—Urinary tract infection—Mesalazine—Crohn's disease	0.00321	0.00744	CcSEcCtD
Ondansetron—CYP2E1—lymphoid tissue—Crohn's disease	0.0032	0.0116	CbGeAlD
Ondansetron—CYP2E1—digestive system—Crohn's disease	0.00316	0.0114	CbGeAlD
Ondansetron—Hiccups—Prednisone—Crohn's disease	0.00313	0.00724	CcSEcCtD
Ondansetron—Hepatobiliary disease—Mesalazine—Crohn's disease	0.00313	0.00723	CcSEcCtD
Ondansetron—Erythema multiforme—Azathioprine—Crohn's disease	0.00308	0.00713	CcSEcCtD
Ondansetron—Body temperature increased—Mercaptopurine—Crohn's disease	0.00307	0.00711	CcSEcCtD
Ondansetron—Haemoglobin—Mesalazine—Crohn's disease	0.00298	0.0069	CcSEcCtD
Ondansetron—Haemorrhage—Mesalazine—Crohn's disease	0.00297	0.00687	CcSEcCtD
Ondansetron—Immune system disorder—Azathioprine—Crohn's disease	0.00294	0.00681	CcSEcCtD
Ondansetron—Mediastinal disorder—Azathioprine—Crohn's disease	0.00294	0.00679	CcSEcCtD
Ondansetron—Chills—Azathioprine—Crohn's disease	0.00292	0.00676	CcSEcCtD
Ondansetron—Arrhythmia—Azathioprine—Crohn's disease	0.00291	0.00673	CcSEcCtD
Ondansetron—Hypersensitivity—Mercaptopurine—Crohn's disease	0.00286	0.00662	CcSEcCtD
Ondansetron—Erythema multiforme—Mesalazine—Crohn's disease	0.00281	0.00649	CcSEcCtD
Ondansetron—Eye disorder—Mesalazine—Crohn's disease	0.00277	0.00642	CcSEcCtD
Ondansetron—Cardiac disorder—Mesalazine—Crohn's disease	0.00275	0.00637	CcSEcCtD
Ondansetron—Angiopathy—Mesalazine—Crohn's disease	0.00269	0.00623	CcSEcCtD
Ondansetron—Immune system disorder—Mesalazine—Crohn's disease	0.00268	0.0062	CcSEcCtD
Ondansetron—Mediastinal disorder—Mesalazine—Crohn's disease	0.00268	0.00619	CcSEcCtD
Ondansetron—Chills—Mesalazine—Crohn's disease	0.00266	0.00616	CcSEcCtD
Ondansetron—Diarrhoea—Mercaptopurine—Crohn's disease	0.00266	0.00615	CcSEcCtD
Ondansetron—Ill-defined disorder—Azathioprine—Crohn's disease	0.00263	0.00609	CcSEcCtD
Ondansetron—Erythema—Mesalazine—Crohn's disease	0.00258	0.00598	CcSEcCtD
Ondansetron—Malaise—Azathioprine—Crohn's disease	0.00256	0.00592	CcSEcCtD
Ondansetron—Flatulence—Mesalazine—Crohn's disease	0.00255	0.00589	CcSEcCtD
Ondansetron—CYP3A4—digestive system—Crohn's disease	0.00254	0.00919	CbGeAlD
Ondansetron—CYP2D6—digestive system—Crohn's disease	0.0025	0.00905	CbGeAlD
Ondansetron—Vomiting—Mercaptopurine—Crohn's disease	0.00247	0.00572	CcSEcCtD
Ondansetron—Rash—Mercaptopurine—Crohn's disease	0.00245	0.00567	CcSEcCtD
Ondansetron—Dermatitis—Mercaptopurine—Crohn's disease	0.00245	0.00566	CcSEcCtD
Ondansetron—Vision blurred—Mesalazine—Crohn's disease	0.00244	0.00563	CcSEcCtD
Ondansetron—Tremor—Mesalazine—Crohn's disease	0.00242	0.0056	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.0024	0.00555	CcSEcCtD
Ondansetron—Ill-defined disorder—Mesalazine—Crohn's disease	0.0024	0.00555	CcSEcCtD
Ondansetron—Discomfort—Azathioprine—Crohn's disease	0.00239	0.00552	CcSEcCtD
Ondansetron—Angioedema—Mesalazine—Crohn's disease	0.00236	0.00546	CcSEcCtD
Ondansetron—KCNH2—lymph node—Crohn's disease	0.00235	0.00847	CbGeAlD
Ondansetron—Malaise—Mesalazine—Crohn's disease	0.00233	0.00539	CcSEcCtD
Ondansetron—Syncope—Mesalazine—Crohn's disease	0.00232	0.00536	CcSEcCtD
Ondansetron—Palpitations—Mesalazine—Crohn's disease	0.00228	0.00528	CcSEcCtD
Ondansetron—Loss of consciousness—Mesalazine—Crohn's disease	0.00227	0.00525	CcSEcCtD
Ondansetron—Cough—Mesalazine—Crohn's disease	0.00225	0.00522	CcSEcCtD
Ondansetron—Skin disorder—Azathioprine—Crohn's disease	0.00225	0.0052	CcSEcCtD
Ondansetron—Chest pain—Mesalazine—Crohn's disease	0.0022	0.00509	CcSEcCtD
Ondansetron—Anxiety—Mesalazine—Crohn's disease	0.00219	0.00507	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.00218	0.00505	CcSEcCtD
Ondansetron—Discomfort—Mesalazine—Crohn's disease	0.00217	0.00503	CcSEcCtD
Ondansetron—Hypotension—Azathioprine—Crohn's disease	0.00216	0.005	CcSEcCtD
Ondansetron—Dry mouth—Mesalazine—Crohn's disease	0.00215	0.00498	CcSEcCtD
Ondansetron—Anaphylactic shock—Mesalazine—Crohn's disease	0.00211	0.00488	CcSEcCtD
Ondansetron—Shock—Mesalazine—Crohn's disease	0.00207	0.0048	CcSEcCtD
Ondansetron—Nervous system disorder—Mesalazine—Crohn's disease	0.00207	0.00478	CcSEcCtD
Ondansetron—Hypokalaemia—Prednisone—Crohn's disease	0.00207	0.00478	CcSEcCtD
Ondansetron—Tachycardia—Mesalazine—Crohn's disease	0.00206	0.00476	CcSEcCtD
Ondansetron—Skin disorder—Mesalazine—Crohn's disease	0.00205	0.00474	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.002	0.00462	CcSEcCtD
Ondansetron—Hypotension—Mesalazine—Crohn's disease	0.00197	0.00456	CcSEcCtD
Ondansetron—Feeling abnormal—Azathioprine—Crohn's disease	0.00191	0.00441	CcSEcCtD
Ondansetron—Paraesthesia—Mesalazine—Crohn's disease	0.00189	0.00438	CcSEcCtD
Ondansetron—Gastrointestinal pain—Azathioprine—Crohn's disease	0.00189	0.00438	CcSEcCtD
Ondansetron—Dyspnoea—Mesalazine—Crohn's disease	0.00188	0.00435	CcSEcCtD
Ondansetron—Somnolence—Mesalazine—Crohn's disease	0.00187	0.00434	CcSEcCtD
Ondansetron—Abdominal pain—Azathioprine—Crohn's disease	0.00183	0.00423	CcSEcCtD
Ondansetron—Body temperature increased—Azathioprine—Crohn's disease	0.00183	0.00423	CcSEcCtD
Ondansetron—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.00182	0.00421	CcSEcCtD
Ondansetron—Fatigue—Mesalazine—Crohn's disease	0.00182	0.00421	CcSEcCtD
Ondansetron—Pain—Mesalazine—Crohn's disease	0.0018	0.00417	CcSEcCtD
Ondansetron—Constipation—Mesalazine—Crohn's disease	0.0018	0.00417	CcSEcCtD
Ondansetron—Feeling abnormal—Mesalazine—Crohn's disease	0.00174	0.00402	CcSEcCtD
Ondansetron—Acute coronary syndrome—Prednisone—Crohn's disease	0.00172	0.00399	CcSEcCtD
Ondansetron—Gastrointestinal pain—Mesalazine—Crohn's disease	0.00172	0.00399	CcSEcCtD
Ondansetron—Myocardial infarction—Prednisone—Crohn's disease	0.00171	0.00397	CcSEcCtD
Ondansetron—Hypersensitivity—Azathioprine—Crohn's disease	0.00171	0.00395	CcSEcCtD
Ondansetron—Urticaria—Mesalazine—Crohn's disease	0.00168	0.00388	CcSEcCtD
Ondansetron—Body temperature increased—Mesalazine—Crohn's disease	0.00167	0.00386	CcSEcCtD
Ondansetron—Abdominal pain—Mesalazine—Crohn's disease	0.00167	0.00386	CcSEcCtD
Ondansetron—Bradycardia—Prednisone—Crohn's disease	0.0016	0.0037	CcSEcCtD
Ondansetron—Diarrhoea—Azathioprine—Crohn's disease	0.00158	0.00366	CcSEcCtD
Ondansetron—Haemoglobin—Prednisone—Crohn's disease	0.00158	0.00365	CcSEcCtD
Ondansetron—Haemorrhage—Prednisone—Crohn's disease	0.00157	0.00363	CcSEcCtD
Ondansetron—Hypersensitivity—Mesalazine—Crohn's disease	0.00155	0.00359	CcSEcCtD
Ondansetron—Dizziness—Azathioprine—Crohn's disease	0.00153	0.00354	CcSEcCtD
Ondansetron—Asthenia—Mesalazine—Crohn's disease	0.00151	0.0035	CcSEcCtD
Ondansetron—Pruritus—Mesalazine—Crohn's disease	0.00149	0.00345	CcSEcCtD
Ondansetron—Vomiting—Azathioprine—Crohn's disease	0.00147	0.00341	CcSEcCtD
Ondansetron—Eye disorder—Prednisone—Crohn's disease	0.00147	0.0034	CcSEcCtD
Ondansetron—Rash—Azathioprine—Crohn's disease	0.00146	0.00338	CcSEcCtD
Ondansetron—Dermatitis—Azathioprine—Crohn's disease	0.00146	0.00337	CcSEcCtD
Ondansetron—Flushing—Prednisone—Crohn's disease	0.00146	0.00337	CcSEcCtD
Ondansetron—Headache—Azathioprine—Crohn's disease	0.00145	0.00336	CcSEcCtD
Ondansetron—Diarrhoea—Mesalazine—Crohn's disease	0.00144	0.00334	CcSEcCtD
Ondansetron—Angiopathy—Prednisone—Crohn's disease	0.00142	0.0033	CcSEcCtD
Ondansetron—Immune system disorder—Prednisone—Crohn's disease	0.00142	0.00328	CcSEcCtD
Ondansetron—Arrhythmia—Prednisone—Crohn's disease	0.0014	0.00325	CcSEcCtD
Ondansetron—Dizziness—Mesalazine—Crohn's disease	0.00139	0.00323	CcSEcCtD
Ondansetron—Erythema—Prednisone—Crohn's disease	0.00137	0.00316	CcSEcCtD
Ondansetron—Vomiting—Mesalazine—Crohn's disease	0.00134	0.0031	CcSEcCtD
Ondansetron—Rash—Mesalazine—Crohn's disease	0.00133	0.00308	CcSEcCtD
Ondansetron—Dermatitis—Mesalazine—Crohn's disease	0.00133	0.00307	CcSEcCtD
Ondansetron—Headache—Mesalazine—Crohn's disease	0.00132	0.00306	CcSEcCtD
Ondansetron—Vision blurred—Prednisone—Crohn's disease	0.00129	0.00298	CcSEcCtD
Ondansetron—Ill-defined disorder—Prednisone—Crohn's disease	0.00127	0.00293	CcSEcCtD
Ondansetron—Agitation—Prednisone—Crohn's disease	0.00126	0.00291	CcSEcCtD
Ondansetron—Angioedema—Prednisone—Crohn's disease	0.00125	0.00289	CcSEcCtD
Ondansetron—Malaise—Prednisone—Crohn's disease	0.00123	0.00285	CcSEcCtD
Ondansetron—Syncope—Prednisone—Crohn's disease	0.00123	0.00284	CcSEcCtD
Ondansetron—Loss of consciousness—Prednisone—Crohn's disease	0.0012	0.00278	CcSEcCtD
Ondansetron—Convulsion—Prednisone—Crohn's disease	0.00118	0.00274	CcSEcCtD
Ondansetron—Anxiety—Prednisone—Crohn's disease	0.00116	0.00268	CcSEcCtD
Ondansetron—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.00116	0.00267	CcSEcCtD
Ondansetron—Discomfort—Prednisone—Crohn's disease	0.00115	0.00266	CcSEcCtD
Ondansetron—Anaphylactic shock—Prednisone—Crohn's disease	0.00112	0.00258	CcSEcCtD
Ondansetron—Shock—Prednisone—Crohn's disease	0.0011	0.00254	CcSEcCtD
Ondansetron—Nervous system disorder—Prednisone—Crohn's disease	0.00109	0.00253	CcSEcCtD
Ondansetron—Tachycardia—Prednisone—Crohn's disease	0.00109	0.00252	CcSEcCtD
Ondansetron—Skin disorder—Prednisone—Crohn's disease	0.00108	0.00251	CcSEcCtD
Ondansetron—Paraesthesia—Prednisone—Crohn's disease	0.001	0.00232	CcSEcCtD
Ondansetron—Fatigue—Prednisone—Crohn's disease	0.000962	0.00223	CcSEcCtD
Ondansetron—Constipation—Prednisone—Crohn's disease	0.000954	0.00221	CcSEcCtD
Ondansetron—Feeling abnormal—Prednisone—Crohn's disease	0.000919	0.00213	CcSEcCtD
Ondansetron—Gastrointestinal pain—Prednisone—Crohn's disease	0.000912	0.00211	CcSEcCtD
Ondansetron—Urticaria—Prednisone—Crohn's disease	0.000886	0.00205	CcSEcCtD
Ondansetron—Body temperature increased—Prednisone—Crohn's disease	0.000882	0.00204	CcSEcCtD
Ondansetron—Abdominal pain—Prednisone—Crohn's disease	0.000882	0.00204	CcSEcCtD
Ondansetron—Hypersensitivity—Prednisone—Crohn's disease	0.000822	0.0019	CcSEcCtD
Ondansetron—Asthenia—Prednisone—Crohn's disease	0.000801	0.00185	CcSEcCtD
Ondansetron—Pruritus—Prednisone—Crohn's disease	0.000789	0.00183	CcSEcCtD
Ondansetron—Diarrhoea—Prednisone—Crohn's disease	0.000763	0.00177	CcSEcCtD
Ondansetron—Dizziness—Prednisone—Crohn's disease	0.000738	0.00171	CcSEcCtD
Ondansetron—Vomiting—Prednisone—Crohn's disease	0.000709	0.00164	CcSEcCtD
Ondansetron—Rash—Prednisone—Crohn's disease	0.000704	0.00163	CcSEcCtD
Ondansetron—Dermatitis—Prednisone—Crohn's disease	0.000703	0.00163	CcSEcCtD
Ondansetron—Headache—Prednisone—Crohn's disease	0.000699	0.00162	CcSEcCtD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.000446	0.00153	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—RASGRP1—Crohn's disease	0.000443	0.00152	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—CCR6—Crohn's disease	0.000439	0.00151	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—PTGER4—Crohn's disease	0.000438	0.00151	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—PTGER4—Crohn's disease	0.000438	0.0015	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000428	0.00147	CbGpPWpGaD
Ondansetron—CYP1A2—Metapathway biotransformation—GPX4—Crohn's disease	0.000425	0.00146	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CCR9—Crohn's disease	0.000424	0.00146	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—MLN—Crohn's disease	0.000423	0.00146	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—GPR65—Crohn's disease	0.000394	0.00136	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—PTGER4—Crohn's disease	0.000386	0.00133	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CCR9—Crohn's disease	0.000385	0.00132	CbGpPWpGaD
Ondansetron—HTR4—GPCR ligand binding—CXCL8—Crohn's disease	0.000384	0.00132	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—CCR6—Crohn's disease	0.000379	0.0013	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CCR9—Crohn's disease	0.000374	0.00129	CbGpPWpGaD
Ondansetron—CYP2C9—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000364	0.00125	CbGpPWpGaD
Ondansetron—HTR3A—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000362	0.00124	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CCR6—Crohn's disease	0.000361	0.00124	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—GPR65—Crohn's disease	0.000358	0.00123	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—IL2RA—Crohn's disease	0.000353	0.00121	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—GPR65—Crohn's disease	0.000348	0.0012	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—Crohn's disease	0.000347	0.00119	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—ACKR2—Crohn's disease	0.000346	0.00119	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CCR9—Crohn's disease	0.00034	0.00117	CbGpPWpGaD
Ondansetron—SLC47A1—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000338	0.00116	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—PTGER4—Crohn's disease	0.000334	0.00115	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—Crohn's disease	0.000333	0.00114	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—MLN—Crohn's disease	0.000328	0.00113	CbGpPWpGaD
Ondansetron—CYP3A4—Metapathway biotransformation—GPX4—Crohn's disease	0.000328	0.00113	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—RBX1—Crohn's disease	0.000326	0.00112	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CCR9—Crohn's disease	0.000323	0.00111	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—IL2RA—Crohn's disease	0.000321	0.0011	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—PTGER4—Crohn's disease	0.000318	0.00109	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—GPR65—Crohn's disease	0.000316	0.00109	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000312	0.00107	CbGpPWpGaD
Ondansetron—CYP1A2—Arachidonic acid metabolism—PTGS2—Crohn's disease	0.000311	0.00107	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000311	0.00107	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL1B—Crohn's disease	0.000309	0.00106	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—ACKR2—Crohn's disease	0.000306	0.00105	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—GPR65—Crohn's disease	0.0003	0.00103	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TAGAP—Crohn's disease	0.0003	0.00103	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCR9—Crohn's disease	0.000293	0.00101	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—MLN—Crohn's disease	0.00029	0.000996	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—UBE2D1—Crohn's disease	0.000286	0.000983	CbGpPWpGaD
Ondansetron—OPRM1—TCR Signaling Pathway—IL6—Crohn's disease	0.000283	0.000972	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CCR6—Crohn's disease	0.000281	0.000966	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—CXCL8—Crohn's disease	0.00028	0.000962	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—RIPK2—Crohn's disease	0.000277	0.000954	CbGpPWpGaD
Ondansetron—OPRM1—Peptide ligand-binding receptors—CXCL8—Crohn's disease	0.000277	0.000952	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—GPR65—Crohn's disease	0.000273	0.000938	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PLA2G4F—Crohn's disease	0.000273	0.000937	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IL3—Crohn's disease	0.000271	0.00093	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—IL1B—Crohn's disease	0.000268	0.000923	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4F—Crohn's disease	0.000267	0.000916	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000265	0.000911	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TAGAP—Crohn's disease	0.000265	0.000911	CbGpPWpGaD
Ondansetron—HTR1B—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000265	0.00091	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—ACKR2—Crohn's disease	0.000264	0.000907	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—RSPO3—Crohn's disease	0.000262	0.000902	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—RASGRP1—Crohn's disease	0.000262	0.000899	CbGpPWpGaD
Ondansetron—HTR3A—Transmembrane transport of small molecules—ALB—Crohn's disease	0.000256	0.00088	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CCR6—Crohn's disease	0.000255	0.000877	CbGpPWpGaD
Ondansetron—KCNH2—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000251	0.000861	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—MLN—Crohn's disease	0.00025	0.00086	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SEL1L—Crohn's disease	0.000249	0.000855	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CCR6—Crohn's disease	0.000248	0.000852	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—PTGER4—Crohn's disease	0.000247	0.00085	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—JAK2—Crohn's disease	0.000238	0.000816	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—SOCS1—Crohn's disease	0.000237	0.000815	CbGpPWpGaD
Ondansetron—OPRM1—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000234	0.000803	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—MTMR3—Crohn's disease	0.000232	0.000797	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—RSPO3—Crohn's disease	0.000232	0.000796	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TAGAP—Crohn's disease	0.000229	0.000786	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCR9—Crohn's disease	0.000228	0.000782	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—MTMR3—Crohn's disease	0.000227	0.000779	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—TYK2—Crohn's disease	0.000226	0.000777	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CCR6—Crohn's disease	0.000225	0.000774	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—PTGER4—Crohn's disease	0.000225	0.000772	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor—TNF—Crohn's disease	0.000225	0.000772	CbGpPWpGaD
Ondansetron—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—Crohn's disease	0.000225	0.000772	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SEL1L—Crohn's disease	0.00022	0.000755	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—PTGER4—Crohn's disease	0.000218	0.00075	CbGpPWpGaD
Ondansetron—HTR4—GPCR downstream signaling—CXCL8—Crohn's disease	0.000217	0.000745	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—JAK2—Crohn's disease	0.000216	0.000741	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CCR6—Crohn's disease	0.000214	0.000736	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—GPR65—Crohn's disease	0.000212	0.000727	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—IL3—Crohn's disease	0.000211	0.000724	CbGpPWpGaD
Ondansetron—HTR1B—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00021	0.000723	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000207	0.00071	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—SMAD3—Crohn's disease	0.000205	0.000704	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000204	0.0007	CbGpPWpGaD
Ondansetron—HTR1A—G alpha (i) signalling events—CXCL8—Crohn's disease	0.000202	0.000693	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCR9—Crohn's disease	0.000201	0.00069	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RSPO3—Crohn's disease	0.0002	0.000687	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—PTGER4—Crohn's disease	0.000198	0.000681	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PLA2G4F—Crohn's disease	0.000197	0.000679	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PLA2G4F—Crohn's disease	0.000197	0.000677	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—CXCL8—Crohn's disease	0.000197	0.000676	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—TNF—Crohn's disease	0.000195	0.000669	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CCR6—Crohn's disease	0.000194	0.000668	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000193	0.000665	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL3—Crohn's disease	0.000191	0.000658	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IL2RA—Crohn's disease	0.00019	0.000651	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SEL1L—Crohn's disease	0.00019	0.000651	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—PTGER4—Crohn's disease	0.000188	0.000648	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—GPR65—Crohn's disease	0.000187	0.000642	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—IL3—Crohn's disease	0.000186	0.000639	CbGpPWpGaD
Ondansetron—OPRM1—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.000186	0.000638	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—RASGRP1—Crohn's disease	0.000185	0.000636	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—FADS1—Crohn's disease	0.000181	0.000621	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—RASGRP1—Crohn's disease	0.00018	0.000618	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—FADS1—Crohn's disease	0.000177	0.000607	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCR9—Crohn's disease	0.000173	0.000596	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—PTGER4—Crohn's disease	0.000171	0.000588	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GPX4—Crohn's disease	0.000169	0.000581	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL3—Crohn's disease	0.000169	0.00058	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—MTMR3—Crohn's disease	0.000168	0.000577	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—MTMR3—Crohn's disease	0.000168	0.000576	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—GPX4—Crohn's disease	0.000165	0.000568	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—RASGRP1—Crohn's disease	0.000163	0.000561	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—GCKR—Crohn's disease	0.000163	0.000561	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—GPR65—Crohn's disease	0.000161	0.000554	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—IL3—Crohn's disease	0.000161	0.000552	CbGpPWpGaD
Ondansetron—HTR1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—Crohn's disease	0.00016	0.000551	CbGpPWpGaD
Ondansetron—HTR1B—GPCR ligand binding—CXCL8—Crohn's disease	0.00016	0.000551	CbGpPWpGaD
Ondansetron—HTR1A—SIDS Susceptibility Pathways—IL6—Crohn's disease	0.000157	0.00054	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—RASGRP1—Crohn's disease	0.000155	0.000534	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CCR6—Crohn's disease	0.000151	0.000518	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—IL2RA—Crohn's disease	0.000148	0.000507	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL3—Crohn's disease	0.000146	0.000501	CbGpPWpGaD
Ondansetron—OPRM1—GPCR ligand binding—CXCL8—Crohn's disease	0.000141	0.000486	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—RASGRP1—Crohn's disease	0.000141	0.000485	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PLA2G4F—Crohn's disease	0.00014	0.000482	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PLA2G4F—Crohn's disease	0.000139	0.000477	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—RBX1—Crohn's disease	0.000136	0.000469	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL2RA—Crohn's disease	0.000134	0.000461	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—TYK2—Crohn's disease	0.000134	0.000459	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CCR6—Crohn's disease	0.000133	0.000457	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—PTGER4—Crohn's disease	0.000133	0.000456	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—FADS1—Crohn's disease	0.000131	0.00045	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—FADS1—Crohn's disease	0.000131	0.000449	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—IL2RA—Crohn's disease	0.00013	0.000448	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—JAK2—Crohn's disease	0.000127	0.000438	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GPX4—Crohn's disease	0.000122	0.000421	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GPX4—Crohn's disease	0.000122	0.00042	CbGpPWpGaD
Ondansetron—HTR1A—GPCR ligand binding—CXCL8—Crohn's disease	0.000122	0.00042	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—RBX1—Crohn's disease	0.00012	0.000414	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—UBE2D1—Crohn's disease	0.00012	0.000411	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—MTMR3—Crohn's disease	0.000119	0.000409	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PLA2G4F—Crohn's disease	0.000119	0.000408	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL2RA—Crohn's disease	0.000118	0.000407	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—GCKR—Crohn's disease	0.000118	0.000407	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—MTMR3—Crohn's disease	0.000118	0.000406	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—GCKR—Crohn's disease	0.000118	0.000406	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—PTGER4—Crohn's disease	0.000117	0.000403	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—CXCL8—Crohn's disease	0.000116	0.0004	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—RIPK2—Crohn's disease	0.000116	0.000398	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CCR6—Crohn's disease	0.000115	0.000395	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL3—Crohn's disease	0.000113	0.000389	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—IL2RA—Crohn's disease	0.000112	0.000386	CbGpPWpGaD
Ondansetron—HTR4—Signaling by GPCR—IL6—Crohn's disease	0.000111	0.00038	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—RASGRP1—Crohn's disease	0.000109	0.000376	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—UBE2D1—Crohn's disease	0.000106	0.000363	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RBX1—Crohn's disease	0.000104	0.000357	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—RIPK2—Crohn's disease	0.000102	0.000352	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL2RA—Crohn's disease	0.000102	0.000351	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—PTGER4—Crohn's disease	0.000101	0.000347	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—MTMR3—Crohn's disease	0.000101	0.000347	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL3—Crohn's disease	9.98e-05	0.000343	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—JAK2—Crohn's disease	9.92e-05	0.000341	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SOCS1—Crohn's disease	9.91e-05	0.00034	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—RASGRP1—Crohn's disease	9.65e-05	0.000332	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—TYK2—Crohn's disease	9.45e-05	0.000325	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—STAT3—Crohn's disease	9.35e-05	0.000321	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—FADS1—Crohn's disease	9.28e-05	0.000319	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—FADS1—Crohn's disease	9.2e-05	0.000316	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PLA2G4F—Crohn's disease	9.16e-05	0.000315	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—UBE2D1—Crohn's disease	9.11e-05	0.000313	CbGpPWpGaD
Ondansetron—HTR1B—GPCR downstream signaling—CXCL8—Crohn's disease	9.06e-05	0.000311	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—JAK2—Crohn's disease	9.01e-05	0.00031	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RIPK2—Crohn's disease	8.83e-05	0.000303	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—JAK2—Crohn's disease	8.76e-05	0.000301	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SOCS1—Crohn's disease	8.74e-05	0.0003	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GPX4—Crohn's disease	8.69e-05	0.000299	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GPX4—Crohn's disease	8.62e-05	0.000296	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL3—Crohn's disease	8.61e-05	0.000296	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—SMAD3—Crohn's disease	8.55e-05	0.000294	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—GCKR—Crohn's disease	8.39e-05	0.000288	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—TYK2—Crohn's disease	8.34e-05	0.000286	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—RASGRP1—Crohn's disease	8.33e-05	0.000286	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—GCKR—Crohn's disease	8.32e-05	0.000286	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—CXCL8—Crohn's disease	8.22e-05	0.000283	CbGpPWpGaD
Ondansetron—OPRM1—GPCR downstream signaling—CXCL8—Crohn's disease	7.99e-05	0.000275	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—JAK2—Crohn's disease	7.95e-05	0.000273	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL2RA—Crohn's disease	7.92e-05	0.000272	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—FADS1—Crohn's disease	7.86e-05	0.00027	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—MTMR3—Crohn's disease	7.79e-05	0.000268	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—JAK2—Crohn's disease	7.56e-05	0.00026	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—SMAD3—Crohn's disease	7.55e-05	0.000259	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SOCS1—Crohn's disease	7.55e-05	0.000259	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GPX4—Crohn's disease	7.36e-05	0.000253	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—CXCL8—Crohn's disease	7.26e-05	0.000249	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—TYK2—Crohn's disease	7.2e-05	0.000247	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—GCKR—Crohn's disease	7.11e-05	0.000244	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL2RA—Crohn's disease	6.99e-05	0.00024	CbGpPWpGaD
Ondansetron—HTR1A—GPCR downstream signaling—CXCL8—Crohn's disease	6.9e-05	0.000237	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—JAK2—Crohn's disease	6.86e-05	0.000236	CbGpPWpGaD
Ondansetron—HTR4—Signaling Pathways—IL6—Crohn's disease	6.53e-05	0.000224	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—SMAD3—Crohn's disease	6.52e-05	0.000224	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—CXCL8—Crohn's disease	6.27e-05	0.000215	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—FADS1—Crohn's disease	6.07e-05	0.000209	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL2RA—Crohn's disease	6.03e-05	0.000207	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.95e-05	0.000204	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GPX4—Crohn's disease	5.68e-05	0.000195	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—TYK2—Crohn's disease	5.58e-05	0.000192	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—GCKR—Crohn's disease	5.49e-05	0.000189	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—JAK2—Crohn's disease	5.32e-05	0.000183	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	5.2e-05	0.000179	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—ALB—Crohn's disease	5.2e-05	0.000179	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—ALB—Crohn's disease	5.08e-05	0.000175	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—TYK2—Crohn's disease	4.92e-05	0.000169	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—CXCL8—Crohn's disease	4.86e-05	0.000167	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—JAK2—Crohn's disease	4.7e-05	0.000161	CbGpPWpGaD
Ondansetron—HTR1B—Signaling by GPCR—IL6—Crohn's disease	4.62e-05	0.000159	CbGpPWpGaD
Ondansetron—CYP3A7—Metabolism—PTGS2—Crohn's disease	4.55e-05	0.000156	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—Crohn's disease	4.45e-05	0.000153	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—CXCL8—Crohn's disease	4.29e-05	0.000147	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—TYK2—Crohn's disease	4.25e-05	0.000146	CbGpPWpGaD
Ondansetron—OPRM1—Signaling by GPCR—IL6—Crohn's disease	4.08e-05	0.00014	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—JAK2—Crohn's disease	4.06e-05	0.000139	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—STAT3—Crohn's disease	3.91e-05	0.000134	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—ALB—Crohn's disease	3.76e-05	0.000129	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—ALB—Crohn's disease	3.76e-05	0.000129	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—CXCL8—Crohn's disease	3.7e-05	0.000127	CbGpPWpGaD
Ondansetron—HTR1A—Signaling by GPCR—IL6—Crohn's disease	3.52e-05	0.000121	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—STAT3—Crohn's disease	3.45e-05	0.000118	CbGpPWpGaD
Ondansetron—CYP2E1—Metabolism—PTGS2—Crohn's disease	3.29e-05	0.000113	CbGpPWpGaD
Ondansetron—CYP3A5—Metabolism—PTGS2—Crohn's disease	3.29e-05	0.000113	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—STAT3—Crohn's disease	2.98e-05	0.000102	CbGpPWpGaD
Ondansetron—HTR1B—Signaling Pathways—IL6—Crohn's disease	2.73e-05	9.38e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—ALB—Crohn's disease	2.67e-05	9.18e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—ALB—Crohn's disease	2.65e-05	9.1e-05	CbGpPWpGaD
Ondansetron—OPRM1—Signaling Pathways—IL6—Crohn's disease	2.41e-05	8.28e-05	CbGpPWpGaD
Ondansetron—CYP2D6—Metabolism—PTGS2—Crohn's disease	2.34e-05	8.03e-05	CbGpPWpGaD
Ondansetron—CYP2C9—Metabolism—PTGS2—Crohn's disease	2.32e-05	7.96e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—ALB—Crohn's disease	2.26e-05	7.78e-05	CbGpPWpGaD
Ondansetron—HTR1A—Signaling Pathways—IL6—Crohn's disease	2.08e-05	7.14e-05	CbGpPWpGaD
Ondansetron—CYP1A2—Metabolism—PTGS2—Crohn's disease	1.98e-05	6.8e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—ALB—Crohn's disease	1.75e-05	6e-05	CbGpPWpGaD
Ondansetron—CYP3A4—Metabolism—PTGS2—Crohn's disease	1.53e-05	5.25e-05	CbGpPWpGaD
